Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 492

1.

Circulating unconventional T cell subsets during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia.

Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Kato S, Takahashi S, Tojo A.

Eur J Haematol. 2019 Sep 11. doi: 10.1111/ejh.13328. [Epub ahead of print]

PMID:
31512295
2.

Efficacy and safety of micafungin in unrelated cord blood transplant recipients.

Yasu T, Konuma T, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Takahashi S, Tojo A.

Ann Hematol. 2019 Sep 7. doi: 10.1007/s00277-019-03790-z. [Epub ahead of print]

PMID:
31494737
3.

Early fluid overload predicts higher non-relapse and overall mortality in adults after single-unit cord blood transplantation.

Konuma T, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Takahashi S, Tojo A.

Bone Marrow Transplant. 2019 Aug 13. doi: 10.1038/s41409-019-0634-x. [Epub ahead of print]

PMID:
31409868
4.

Enhanced bone regeneration capability of chitosan sponge coated with TiO2 nanoparticles.

Ikono R, Li N, Pratama NH, Vibriani A, Yuniarni DR, Luthfansyah M, Bachtiar BM, Bachtiar EW, Mulia K, Nasikin M, Kagami H, Li X, Mardliyati E, Rochman NT, Nagamura-Inoue T, Tojo A.

Biotechnol Rep (Amst). 2019 Jun 5;24:e00350. doi: 10.1016/j.btre.2019.e00350. eCollection 2019 Dec.

5.

Nanochitosan antimicrobial activity against Streptococcus mutans and Candida albicans dual-species biofilms.

Ikono R, Vibriani A, Wibowo I, Saputro KE, Muliawan W, Bachtiar BM, Mardliyati E, Bachtiar EW, Rochman NT, Kagami H, Xianqi L, Nagamura-Inoue T, Tojo A.

BMC Res Notes. 2019 Jul 8;12(1):383. doi: 10.1186/s13104-019-4422-x.

6.

Desflurane impairs hippocampal learning on day 1 of exposure: a prospective laboratory study in rats.

Tojo A, Uchimoto K, Inagawa G, Goto T.

BMC Anesthesiol. 2019 Jul 4;19(1):119. doi: 10.1186/s12871-019-0793-8.

7.

T memory stem cells after allogeneic haematopoietic cell transplantation: unique long-term kinetics and influence of chronic graft-versus-host disease.

Jimbo K, Konuma T, Watanabe E, Kohara C, Mizukami M, Nagai E, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Takahashi S, Tojo A.

Br J Haematol. 2019 Sep;186(6):866-878. doi: 10.1111/bjh.15995. Epub 2019 May 28.

PMID:
31135974
8.

Red blood cell transfusion burden by day 30 predicts mortality in adults after single-unit cord blood transplantation.

Konuma T, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Nagamura-Inoue T, Takahashi S, Tojo A.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0555-8. [Epub ahead of print]

PMID:
31089286
9.

The first case of elderly TCF3-HLF-positive B-cell acute lymphoblastic leukemia.

Takeda R, Yokoyama K, Ogawa M, Kawamata T, Fukuyama T, Kondoh K, Takei T, Nakamura S, Ito M, Yusa N, Shimizu E, Ohno N, Uchimaru K, Yamaguchi R, Imoto S, Miyano S, Tojo A.

Leuk Lymphoma. 2019 May 6:1-4. doi: 10.1080/10428194.2019.1602267. [Epub ahead of print] No abstract available.

PMID:
31058556
10.

HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action.

Imai Y, Hirano M, Kobayashi M, Futami M, Tojo A.

Cancers (Basel). 2019 Apr 4;11(4). pii: E475. doi: 10.3390/cancers11040475. Review.

11.

Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.

Nakamura S, Yokoyama K, Shimizu E, Yusa N, Kondoh K, Ogawa M, Takei T, Kobayashi A, Ito M, Isobe M, Konuma T, Kato S, Kasajima R, Wada Y, Nagamura-Inoue T, Yamaguchi R, Takahashi S, Imoto S, Miyano S, Tojo A.

Blood. 2019 Jun 20;133(25):2682-2695. doi: 10.1182/blood-2018-10-880690. Epub 2019 Apr 1.

PMID:
30936070
12.

Cytokine Profile in Sweet's Syndrome under the Treatment of Pulmonary Toxoplasmosis Complicated with Myelodysplastic Syndrome.

Matsuzawa Y, Adachi E, Takahashi A, Sato H, Lim LA, Komatsu T, Koibuchi T, Nagamura-Inoue T, Tojo A, Nagayama H, Yotsuyanagi H.

Intern Med. 2019 Jul 15;58(14):2079-2083. doi: 10.2169/internalmedicine.2372-18. Epub 2019 Mar 28.

13.

Fungemia due to Fusarium solani under low-dose liposomal amphotericin B in a patient after cord blood transplantation.

Konuma T, Takahashi S, Kiyuna T, Misawa Y, Suzuki M, Isobe M, Jimbo K, Mizusawa M, Kato S, Takahashi S, Tojo A.

J Infect Chemother. 2019 Aug;25(8):635-638. doi: 10.1016/j.jiac.2019.02.020. Epub 2019 Mar 23.

PMID:
30910505
14.

Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database.

Oshima Y, Takahashi S, Tani K, Tojo A.

Cytokine. 2019 Jul;119:47-51. doi: 10.1016/j.cyto.2019.02.013. Epub 2019 Mar 13.

PMID:
30875590
15.

Myeloablative single-unit cord blood transplantation overcomes the negative prognostic impact of FLT3-ITD in adult acute myeloid leukemia.

Konuma T, Kato S, Oiwa-Monna M, Mizusawa M, Isobe M, Yokoyama K, Takahashi S, Tojo A.

Leuk Lymphoma. 2019 Feb 18:1-4. doi: 10.1080/10428194.2019.1579325. [Epub ahead of print] No abstract available.

PMID:
30775946
16.

Development of Pre-Engraftment Syndrome, but Not Acute Graft-versus-Host Disease, Reduces Relapse Rate of Acute Myelogenous Leukemia after Single Cord Blood Transplantation.

Isobe M, Konuma T, Kato S, Tanoue S, Mizusawa M, Oiwa-Monna M, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1187-1196. doi: 10.1016/j.bbmt.2019.02.007. Epub 2019 Feb 13.

PMID:
30771495
17.

Adult T-Cell Leukemia/Lymphoma-Related Ocular Manifestations: Analysis of the First Large-Scale Nationwide Survey.

Kamoi K, Okayama A, Izumo S, Hamaguchi I, Uchimaru K, Tojo A, Ohno-Matsui K.

Front Microbiol. 2019 Jan 8;9:3240. doi: 10.3389/fmicb.2018.03240. eCollection 2018.

18.

The Prognostic Impact of Pretransplantation Inflammatory and Nutritional Status in Adult Patients after Myeloablative Single Cord Blood Transplantation.

Miyashita E, Konuma T, Kataoka J, Oiwa-Monna M, Mizusawa M, Isobe M, Kato S, Sato T, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2019 May;25(5):981-988. doi: 10.1016/j.bbmt.2019.01.006. Epub 2019 Jan 11.

PMID:
30639818
19.

Escape hematopoiesis by donor-derived 6pLOH(+) hematopoietic stem cells in a marrow transplant recipient with late graft failure.

Hino T, Imi T, Hangaishi A, Kamoda Y, Iizuka H, Hirao M, Kida M, Tojo A, Nakao S, Usuki K.

Bone Marrow Transplant. 2019 Jul;54(7):1129-1132. doi: 10.1038/s41409-018-0420-1. Epub 2019 Jan 10. No abstract available.

PMID:
30631099
20.

Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.

Tominaga K, Minato H, Murayama T, Sasahara A, Nishimura T, Kiyokawa E, Kanauchi H, Shimizu S, Sato A, Nishioka K, Tsuji EI, Yano M, Ogawa T, Ishii H, Mori M, Akashi K, Okamoto K, Tanabe M, Tada KI, Tojo A, Gotoh N.

Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):625-630. doi: 10.1073/pnas.1806851116. Epub 2018 Dec 26.

21.

Nested Polymerase Chain Reaction with Specific Primers for Mucorales in the Serum of Patients with Hematological Malignancies.

Hirano M, Ota Y, Koibuchi T, Takei T, Takeda R, Kawamata T, Yokoyama K, Uchimaru K, Yotsuyanagi H, Imai Y, Tojo A.

Jpn J Infect Dis. 2019 May 23;72(3):196-198. doi: 10.7883/yoken.JJID.2018.379. Epub 2018 Dec 25.

22.

Mesenchymal stromal cells as a potential therapeutic for neurological disorders.

Mukai T, Tojo A, Nagamura-Inoue T.

Regen Ther. 2018 Aug 24;9:32-37. doi: 10.1016/j.reth.2018.08.001. eCollection 2018 Dec. Review.

23.

Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.

Nishimura T, Nakata A, Chen X, Nishi K, Meguro-Horike M, Sasaki S, Kita K, Horike SI, Saitoh K, Kato K, Igarashi K, Murayama T, Kohno S, Takahashi C, Mukaida N, Yano S, Soga T, Tojo A, Gotoh N.

Oncogene. 2019 Apr;38(14):2464-2481. doi: 10.1038/s41388-018-0589-1. Epub 2018 Dec 7.

24.

Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose Total Body Irradiation/Granulocyte Colony-Stimulating Factor-Combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients with Nonremission Myeloid Malignancies.

Konuma T, Kato S, Isobe M, Mizusawa M, Oiwa-Monna M, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2019 Apr;25(4):764-770. doi: 10.1016/j.bbmt.2018.12.004. Epub 2018 Dec 7.

PMID:
30529460
25.

Risk factors and survival impact of readmission after single-unit cord blood transplantation for adults.

Yamagishi Y, Konuma T, Miwa Y, Oiwa-Monna M, Tanoue S, Isobe M, Jimbo K, Mizusawa M, Narita H, Kobayashi K, Kato S, Takahashi S, Tojo A.

Int J Hematol. 2019 Jan;109(1):115-124. doi: 10.1007/s12185-018-2539-7. Epub 2018 Oct 9.

PMID:
30302739
26.

Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes.

Yokoyama K, Shimizu E, Yokoyama N, Nakamura S, Kasajima R, Ogawa M, Takei T, Ito M, Kobayashi A, Yamaguchi R, Imoto S, Miyano S, Tojo A.

Blood Adv. 2018 Oct 9;2(19):2513-2521. doi: 10.1182/bloodadvances.2017010744.

27.

Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment.

Kobayashi M, Tojo A.

Cancer Sci. 2018 Dec;109(12):3707-3713. doi: 10.1111/cas.13817. Epub 2018 Oct 30. Review.

28.

Electron microscopy of urinary sediments in Fabry disease.

Murayama Y, Uchida M, Tojo A, Ishimitsu T.

Kidney Int. 2018 Oct;94(4):834. doi: 10.1016/j.kint.2018.04.010. No abstract available.

29.

Efficacy and Safety of Low-Dose Liposomal Amphotericin B in Adult Patients Undergoing Unrelated Cord Blood Transplantation.

Yasu T, Konuma T, Oiwa-Monna M, Kato S, Tanoue S, Isobe M, Mizusawa M, Kuroda S, Takahashi S, Tojo A.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01205-18. doi: 10.1128/AAC.01205-18. Print 2018 Nov.

30.

Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.

Hirano M, Jimbo K, Ogawa M, Ochi K, Makiyama J, Kawamata T, Yokoyama K, Tanaka T, Inamoto Y, Yamano Y, Fukuda T, Uchimaru K, Imai Y, Tojo A.

Bone Marrow Transplant. 2018 Nov;53(11):1470-1473. doi: 10.1038/s41409-018-0202-9. Epub 2018 Jul 23. No abstract available.

PMID:
30038356
31.

[II. New Treatment Option for Acute Lymphoblastic Leukemia].

Makiyama J, Tojo A.

Gan To Kagaku Ryoho. 2018 May;45(5):801-805. Japanese. No abstract available.

PMID:
30026441
32.

Effect of Cumulative Intravenous Voriconazole Dose on Renal Function in Hematological Patients.

Yasu T, Konuma T, Kuroda S, Takahashi S, Tojo A.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00507-18. doi: 10.1128/AAC.00507-18. Print 2018 Sep.

33.

Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.

Oshima Y, Tanimoto T, Yuji K, Tojo A.

Mult Scler. 2019 Jul;25(8):1141-1149. doi: 10.1177/1352458518786075. Epub 2018 Jul 9.

PMID:
29985084
34.

Umbilical Cord-Derived Mesenchymal Stromal Cells Contribute to Neuroprotection in Neonatal Cortical Neurons Damaged by Oxygen-Glucose Deprivation.

Mukai T, Tojo A, Nagamura-Inoue T.

Front Neurol. 2018 Jun 15;9:466. doi: 10.3389/fneur.2018.00466. eCollection 2018.

35.

Circulating tumor DNA dynamically predicts response and/or relapse in patients with hematological malignancies.

Nakamura S, Yokoyama K, Yusa N, Ogawa M, Takei T, Kobayashi A, Ito M, Shimizu E, Kasajima R, Wada Y, Yamaguchi R, Imoto S, Nagamura-Inoue T, Miyano S, Tojo A.

Int J Hematol. 2018 Oct;108(4):402-410. doi: 10.1007/s12185-018-2487-2. Epub 2018 Jun 29.

PMID:
29959746
36.

Prevalence of myofascial pain syndrome in patients with incurable cancer.

Ishiki H, Kinkawa J, Watanabe A, Watanabe C, Chiba T, Yasui H, Shimada N, Ariyoshi K, Nojima M, Iwase S, Tojo A, Imai K.

J Bodyw Mov Ther. 2018 Apr;22(2):328-332. doi: 10.1016/j.jbmt.2017.05.005. Epub 2017 May 17.

PMID:
29861227
37.

Does marital status affect the outcomes after allogeneic hematopoietic cell transplantation?

Sato T, Konuma T, Oiwa-Monna M, Tanoue S, Isobe M, Jimbo K, Kasuya F, Hisahara M, Kobayashi K, Kato S, Takahashi S, Tojo A.

Bone Marrow Transplant. 2018 Jun;53(6):774-779. doi: 10.1038/s41409-018-0217-2. Epub 2018 May 24. No abstract available.

PMID:
29795421
38.

Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation for Adults: Risk Factors and Clinical Outcomes.

Tanoue S, Konuma T, Kato S, Oiwa-Monna M, Isobe M, Jimbo K, Takahashi S, Tojo A.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1873-1880. doi: 10.1016/j.bbmt.2018.05.006. Epub 2018 May 10.

39.

Circulating monocyte subsets in human chronic graft-versus-host disease.

Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Oiwa-Monna M, Tanoue S, Isobe M, Jimbo K, Kato S, Takahashi S, Tojo A.

Bone Marrow Transplant. 2018 Dec;53(12):1532-1540. doi: 10.1038/s41409-018-0187-4. Epub 2018 May 4.

PMID:
29728699
40.

Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation.

Takei T, Yokoyama K, Shimizu E, Konuma T, Takahashi S, Yamaguchi R, Imoto S, Miyano S, Tojo A.

Leuk Lymphoma. 2018 Nov;59(11):2755-2756. doi: 10.1080/10428194.2018.1443335. Epub 2018 Apr 12. No abstract available.

PMID:
29648492
41.

The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia.

Ochi K, Fuji S, Takano K, Tajima K, Ito A, Tanaka T, Inamoto Y, Kurosawa S, Kim SW, Tojo A, Fukuda T.

Bone Marrow Transplant. 2018 Aug;53(8):1019-1029. doi: 10.1038/s41409-018-0115-7. Epub 2018 Feb 19.

PMID:
29459664
42.

Monocyte subsets and their phenotypes during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia.

Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Tanoue S, Isobe M, Jimbo K, Kato S, Ohno N, Takahashi S, Tojo A.

Hematol Oncol. 2018 Apr;36(2):451-456. doi: 10.1002/hon.2497. Epub 2018 Feb 12.

PMID:
29431866
43.

[Autologous peripheral blood stem cell transplantation for double-refractory myeloma with K-RAS and N-RAS mutations].

Jimbo K, Yokoyama K, Ogawa M, Hirano M, Ochi K, Kobayashi M, Yusa N, Shimizu E, Kawamata T, Yasui H, Ohno N, Yamaguchi R, Imoto S, Furukawa Y, Miyano S, Imai Y, Tojo A.

Rinsho Ketsueki. 2017;58(12):2380-2385. doi: 10.11406/rinketsu.58.2380. Japanese.

PMID:
29332870
44.

EGFR-TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non-Small Cell Lung Cancer.

Oshima Y, Tanimoto T, Yuji K, Tojo A.

JAMA Oncol. 2018 Aug 1;4(8):1112-1115. doi: 10.1001/jamaoncol.2017.4526.

45.

H+-ATPase blockade reduced renal gluconeogenesis and plasma glucose in a diabetic rat model.

Tojo A, Hatakeyama S, Nangaku M, Ishimitsu T.

Med Mol Morphol. 2018 Jun;51(2):89-95. doi: 10.1007/s00795-017-0175-6. Epub 2018 Jan 9.

46.

Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system.

Ogawa M, Yokoyama K, Hirano M, Jimbo K, Ochi K, Kawamata T, Ohno N, Shimizu E, Yokoyama N, Yamaguchi R, Imoto S, Uchimaru K, Takahashi N, Miyano S, Imai Y, Tojo A.

Br J Haematol. 2018 Dec;183(5):842-845. doi: 10.1111/bjh.15065. Epub 2017 Dec 19. No abstract available.

PMID:
29265350
47.

Simple Determination of Plasma Ponatinib Concentration Using HPLC.

Yasu T, Momo K, Kobayashi S, Kuroda S, Tojo A.

Biol Pharm Bull. 2018 Feb 1;41(2):254-258. doi: 10.1248/bpb.b17-00806. Epub 2017 Dec 6.

48.

Associations of interactions between NLRP3 SNPs and HLA mismatch with acute and extensive chronic graft-versus-host diseases.

Takahashi H, Okayama N, Yamaguchi N, Miyahara Y, Morishima Y, Suehiro Y, Yamasaki T, Tamada K, Takahashi S, Tojo A, Asano S, Tanabe T.

Sci Rep. 2017 Oct 12;7(1):13097. doi: 10.1038/s41598-017-13506-w.

49.

Clinical sequencing in leukemia with the assistance of artificial intelligence.

Tojo A.

Rinsho Ketsueki. 2017;58(10):1913-1917. doi: 10.11406/rinketsu.58.1913. Japanese.

PMID:
28978832
50.

Phenotype-based gene analysis allowed successful diagnosis of X-linked neutropenia associated with a novel WASp mutation.

Kobayashi M, Yokoyama K, Shimizu E, Yusa N, Ito M, Yamaguchi R, Imoto S, Miyano S, Tojo A.

Ann Hematol. 2018 Feb;97(2):367-369. doi: 10.1007/s00277-017-3134-3. Epub 2017 Sep 27. No abstract available.

PMID:
28956125

Supplemental Content

Support Center